Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited)

v3.2.0.727
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Income Statement [Abstract]        
Grant Revenues $ 27,000   $ 53,000  
Operating Expenses:        
Research and Development 1,946,000 $ 888,000 3,505,000 $ 1,853,000
General and Administrative 1,898,000 499,000 2,536,000 1,066,000
Total operating expenses 3,844,000 1,387,000 6,041,000 2,919,000
Loss from operations (3,817,000) $ (1,387,000) (5,988,000) $ (2,919,000)
Other income (expense)        
Interest income 44,000   88,000  
Realized gain (loss) on marketable securities $ (1,685,000) $ 480,000 $ (1,685,000) $ 480,000
Fair value of warrant liabilities in excess of proceeds from financing       (946,000)
Other expense   $ (2,000)   (2,000)
Change in fair value of derivative liabilities $ 2,887,000 5,639,000 $ (11,528,000) 7,744,000
Total other income (expense), net 1,246,000 6,117,000 (13,125,000) 7,276,000
Income (loss) before income taxes (2,571,000) $ 4,730,000 (19,113,000) $ 4,357,000
Income tax expense (52,000)   (52,000)  
Net income (loss) (2,632,000) $ 4,730,000 (19,165,000) $ 4,357,000
Comprehensive income (loss):        
Net loss (2,632,000) 4,730,000 (19,165,000) 4,357,000
Unrealized gain (loss) on marketable securities, net of tax 744,000 3,354,000 (236,000) 1,827,000
Total comprehensive income (loss) $ (1,879,000) $ 8,084,000 $ (19,401,000) $ 6,184,000
Net loss per common share:        
Income (loss) per share, basic $ (0.00) $ 0.01 $ (0.03) $ 0.01
Weighted average common shares outstanding, basic 692,204 326,760 566,816 326,160
Income (loss) per share, fully diluted $ (0.01) $ 0.01 $ (0.03) $ 0.01
Weighted average common shares outstanding, diluted 696,758 326,760 566,816 326,160